Squar Milner Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Squar Milner Financial Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,067	Closed	-$282K	–	214
2020 Q2	$282K	Buy	5,067 +4,893	+2,812%	+$209K	0.16%	159
2020 Q1	$5K	Hold	174	–	–	﹤0.01%	607
2019 Q4	$6K	Sell	174 -4,975	-97%	-$153K	﹤0.01%	631
2019 Q3	$400K	Buy	+5,149	New	+$133K	0.2%	126

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Squar Milner Financial Services's HZNP Position: Q3 2020 in Review

Squar Milner Financial Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2020, closing a stake of 5,067 shares — an estimated $282K sold.

Squar Milner Financial Services first reported a position in HZNP in Q3 2019 and held it in 4 quarters. The position peaked at $400K in Q3 2019. 433 funds tracked by Wall St. Rank hold HZNP as of Q3 2020.

Squar Milner Financial Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2020 after selling out during the quarter.
Squar Milner Financial Services sold 5,067 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2020, an estimated $282K.
Squar Milner Financial Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2019 and held it in 4 quarters.
Squar Milner Financial Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $400K in Q3 2019.
433 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2020.

Based on Squar Milner Financial Services's 13F filing for Q3 2020.